Cargando…

IVIG plus Glucocorticoids versus IVIG Alone in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review and Meta-Analysis

BACKGROUND: There is limited information available regarding the management of multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2. We performed a systematic review and meta-analysis to evaluate the optimal treatment using IVIG alone versus IVIG plus glucocorticoids. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rauniyar, Robin, Mishra, Aman, Kharel, Sanjeev, Giri, Subarna, Rauniyar, Rohit, Yadav, Shikha, Chaudhary, Gajendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965733/ https://www.ncbi.nlm.nih.gov/pubmed/35368517 http://dx.doi.org/10.1155/2022/9458653

Ejemplares similares

Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics
por: DeBiasi, Roberta L.
Publicado: (2021)

Unraveling the mechanisms of IVIG immunotherapy in MIS-C
por: Ganigara, Madhusudan, et al.
Publicado: (2021)

MIS-C Treatment: Is IVIG Always Necessary?
por: Licciardi, Francesco, et al.
Publicado: (2021)

Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?
por: Licciardi, Francesco, et al.
Publicado: (2022)

Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
por: Han, Chun-Ling, et al.
Publicado: (2018)

Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study
por: Zhu, Xiao-Lu, et al.
Publicado: (2022)

Endogenous endophthalmitis and multifocal brain abscess—An interesting case
por: Mishra, Aman, et al.
Publicado: (2021)

Treatment of scleromyxedema with IVIg
por: Moser, David W, et al.
Publicado: (2012)

Safety and efficacy of prophylactic anticoagulation versus therapeutic anticoagulation in hospital‐admitted COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
por: Rauniyar, Robin, et al.
Publicado: (2022)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
por: Wang, Zhouping, et al.
Publicado: (2020)

A Comparative Study of IVIG versus IVIG with IV Methylprednisolone in Guillain–Barre Syndrome
por: Bhattiprolu, Rahi Kiran, et al.
Publicado: (2020)

Cooling down VITT with IVIG
por: Lentz, Steven R.
Publicado: (2021)

Prevalence of Stroke in Asian Patients with Sickle Cell Anemia: A Systematic Review and Meta-Analysis
por: Kuikel, Sandip, et al.
Publicado: (2021)

Study on the Treatment of ITP Mice with IVIG Sourced from Distinct Sex-Special Plasma (DSP-IVIG)
por: Zhang, Wei, et al.
Publicado: (2023)

Eczematous reaction to IVIG for the treatment of dermatomyositis()()
por: Berk-Krauss, J., et al.
Publicado: (2018)

Low-Dose Dexamethasone Following IVIG in Pediatric Inflammatory Multisystem Syndrome in Temporal Association with COVID-19 (PIMS-TC)
por: Meena, Priyanka, et al.
Publicado: (2020)

Therapeutic Window of Intravenous Immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki Disease: a retrospective study
por: Cai, Jiang Hui, et al.
Publicado: (2022)

Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease
por: Zhang, Hao, et al.
Publicado: (2022)

IVIG Treatment and Prognosis in Guillain–Barré Syndrome
por: van Doorn, Pieter A., et al.
Publicado: (2010)

IVIG Effects on Erythrocyte Sedimentation Rate in Children
por: Salehzadeh, Farhad, et al.
Publicado: (2014)

Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
por: De Groot, Anne S., et al.
Publicado: (2013)

IVIG regulates the survival of human but not mouse neutrophils
por: Schneider, Christoph, et al.
Publicado: (2017)

Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations
por: Hooper, John A.
Publicado: (2008)

Desensitization using IVIG alone for living-donor kidney transplant: impact on donor-specific antibodies
por: Ulisses, Luiz Roberto de Sousa, et al.
Publicado: (2022)

COVID-19 MULTISYSTEM INFLAMMATORY SYNDROME IN A YOUNG ADULT: RAPID REVERSAL OF CARDIOGENIC SHOCK WITH IVIG AND STEROIDS
por: CHOHAN, AMAD, et al.
Publicado: (2022)

SCIg vs. IVIg: let’s give patients the choice!
por: Samaan, Kathryn K, et al.
Publicado: (2014)

Dose‐dependent inhibition of demyelination and microglia activation by IVIG
por: Winter, Meike, et al.
Publicado: (2016)

IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome
por: Brem, Maarten D., et al.
Publicado: (2018)

IgG Glyco-Engineering to Improve IVIg Potency
por: Bruggeman, Christine W., et al.
Publicado: (2018)

CIDP prognosis in patients with IVIG treatment‐related fluctuations
por: Cook, Melissa, et al.
Publicado: (2022)

Hydroxychloroquine-Induced Myopathy Responding to Intravenous Immunoglobulin (IVIG)
por: Almoallim, Hani, et al.
Publicado: (2023)

Intravenous Immunoglobulin G (IVIG) Need Assessment Survey Toward Local Manufacturing of IVIG Using a Mini-Pool Plasma Fractionation Technique
por: Bekele, Bisrat, et al.
Publicado: (2023)

Severe late‐onset neutropenia induced by ocrelizumab in a multiple sclerosis patient: A case report
por: Rauniyar, Robin, et al.
Publicado: (2022)

Tubulointerstitial nephritis complicating IVIG therapy for X-linked agammaglobulinemia
por: Sugimoto, Keisuke, et al.
Publicado: (2014)

Is response to IVIG in Chronic Idiopathic Urticaria related to presense of autoantibodies?
por: Rosenfield, Lana, et al.
Publicado: (2014)

Molecular factors modulating the anti-inflammatory activity of IVIg in ITP
por: Schwab, Inessa, et al.
Publicado: (2012)

Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression
por: Paquin-Proulx, Dominic, et al.
Publicado: (2014)

Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications
por: Czajkowsky, Daniel M., et al.
Publicado: (2015)

Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?
por: Sordé, Laetitia, et al.
Publicado: (2017)

2031. False-positive Serologic Results attributable to IVIG therapy
por: Hanson, Kimberly E, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pt35d3sej87qs0o2tl38rlgukf